Lori A. Leslie, MD, and Hoshiyuki Iida, APN, discuss the multidisciplinary approach to treating patients with BTKis for chronic lymphocytic leukemia (CLL), and the evolving treatment landscape.
April 3rd 2023
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process.
Hoshiyuki Iida, APN, discusses his role in the multidisciplinary team in the treatment of patients with chronic lymphocytic leukemia.
April 10th 2023
Lori A. Leslie, MD, an expert on chronic lymphocytic leukemia, provides a comprehensive overview of BTK inhibitors used in the treatment of CLL.
CLL experts offer insights on shared decision-making with patients while selecting treatments.
April 17th 2023
Lori A. Leslie, MD, an expert on CLL, talks about factors that influence treatment decisions.
CLL expert Lori A. Leslie, MD, gives a comprehensive overview of the ALPINE and ELEVATE-RR head-to-head studies of BTK inhibitors in CLL.
April 24th 2023
Insights on supportive care and approaches to managing adverse effects of BTK inhibitors in the treatment of chronic lymphocytic leukemia.
Experts on chronic lymphocytic leukemia discuss how to approach cost considerations and available resources for CLL treatments.
May 1st 2023
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Cancer Causes Me to Live Life With Uncertainty
A Ray of Sunshine on the Oncology Ward
During Cancer, I Find My Inner Goddess With Dinosaurs and Old Movies
Mike Peters of The Alarm Faces Cancer With Rock Optimism on New Album